340 related articles for article (PubMed ID: 9797793)
1. The interaction of diltiazem with lovastatin and pravastatin.
Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
[TBL] [Abstract][Full Text] [Related]
2. The interaction of diltiazem with simvastatin.
Mousa O; Brater DC; Sunblad KJ; Hall SD
Clin Pharmacol Ther; 2000 Mar; 67(3):267-74. PubMed ID: 10741630
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
[TBL] [Abstract][Full Text] [Related]
5. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
[TBL] [Abstract][Full Text] [Related]
6. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM
Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
Neuvonen PJ; Jalava KM
Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
Neuvonen PJ; Kantola T; Kivistö KT
Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.
Reyderman L; Kosoglou T; Boutros T; Seiberling M; Statkevich P
Curr Med Res Opin; 2004 Sep; 20(9):1493-500. PubMed ID: 15383199
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
[TBL] [Abstract][Full Text] [Related]
11. The effects of multiple doses of fenofibrate on the pharmacokinetics of pravastatin and its 3alpha-hydroxy isomeric metabolite.
Gustavson LE; Schweitzer SM; Koehne-Voss S; Achari R; Chira TO; Esslinger HU; Yannicelli HD
J Clin Pharmacol; 2005 Aug; 45(8):947-53. PubMed ID: 16027406
[TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
Kyrklund C; Backman JT; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2003 Jun; 73(6):538-44. PubMed ID: 12811363
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
[TBL] [Abstract][Full Text] [Related]
15. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers.
Lamson M; Phillips G; Shen J; Lukacsko P; Friedhoff L; Niecestro RM
Biopharm Drug Dispos; 2002 May; 23(4):143-9. PubMed ID: 12015788
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.
Derks M; Abt M; Phelan M; Turnbull L; Meneses-Lorente G; Bech N; White AM; Parr G
J Clin Pharmacol; 2010 Oct; 50(10):1188-201. PubMed ID: 20489031
[TBL] [Abstract][Full Text] [Related]
18. Intravenous diltiazem and CYP3A-mediated metabolism.
Masica AL; Azie NE; Brater DC; Hall SD; Jones DR
Br J Clin Pharmacol; 2000 Sep; 50(3):273-6. PubMed ID: 10971313
[TBL] [Abstract][Full Text] [Related]
19. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A
Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
[TBL] [Abstract][Full Text] [Related]
20. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]